Fenoprofen calcium
Fenoprofen calcium Brand names, Fenoprofen calcium Analogs
Fenoprofen calcium Brand Names Mixture
- No information avaliable
Fenoprofen calcium Chemical_Formula
C24H33N3O4
Fenoprofen calcium RX_link
No information avaliable
Fenoprofen calcium fda sheet
Fenoprofen calcium msds (material safety sheet)
Fenoprofen calcium Synthesis Reference
No information avaliable
Fenoprofen calcium Molecular Weight
427.537 g/mol
Fenoprofen calcium Melting Point
No information avaliable
Fenoprofen calcium H2O Solubility
Very slightly soluble
Fenoprofen calcium State
Solid
Fenoprofen calcium LogP
1.876
Fenoprofen calcium Dosage Forms
Tablets (extended release - 500 mg)
Fenoprofen calcium Indication
For the treatment of chronic angina. It should be used in combination with amlodipine, beta-blockers or nitrates.
Fenoprofen calcium Pharmacology
Ranolazine has antianginal and anti-ischemic effects that do not depend upon reductions in heart rate or blood pressure. It is the first new anti-anginal developed in over 20 years.
Fenoprofen calcium Absorption
Absorption is highly variable. After oral administration of ranolazine as a solution, 73% of the dose is systemically available as ranolazine or metabolites. The bioavailability of oral ranolazine relative to that from a solution is 76%.
Fenoprofen calcium side effects and Toxicity
In the event of overdose, the expected symptoms would be dizziness, nausea/vomiting, diplopia, paresthesia, and confusion. Syncope with prolonged loss of consciousness may develop.
Fenoprofen calcium Patient Information
AMITIZA™ may cause nausea. If this occurs, concomitant administration of food with AMITIZA™ may reduce symptoms of nausea. AMITIZA™ should not be administered to patients that have severe diarrhea. Patients should be aware of the possible occurrence of diarrhea during treatment. If the diarrhea becomes severe consult your physician.
Fenoprofen calcium Organisms Affected
Humans and other mammals
